MetaADEDB 2.0 @ LMMD
Tramadol
(PPKXEPBICJTCRU-XMZRARIVSA-N)
Structure
SMILES
COc1cccc(c1)[C@@]1(O)CCCC[C@@H]1CN(C)C.Cl
Molecular Formula:
C16H26ClNO2
Molecular Weight:
299.836
Log P:
3.4366
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
2
TPSA:
32.7
CAS Number(s):
22204-88-2; 36282-47-0; 53611-16-8; 148229-78-1; 194602-08-9
Synonym(s)
1.
Tramadol
2.
Adolonta
3.
Amadol
4.
Biodalgic
5.
Biokanol
6.
Contramal
7.
Jutadol
8.
K-315
9.
MTW-Tramadol
10.
Nobligan
11.
Prontofort
12.
Ranitidin 1A Pharma
13.
Takadol
14.
Theradol
15.
Tiral
16.
Topalgic
17.
Tradol
18.
Tradol-Puren
19.
Tradonal
20.
Tralgiol
21.
Trama 1A Pharma
22.
Trama AbZ
23.
Trama KD
24.
Trama-Dorsch
25.
Tramabeta
26.
Tramadin
27.
Tramadoc
28.
Tramadol 1A
29.
Tramadol AL
30.
Tramadol Asta Medica
31.
Tramadol Basics
32.
Tramadol Bayvit
33.
Tramadol Bexal
34.
Tramadol Cinfa
35.
Tramadol Edigen
36.
Tramadol Heumann
37.
Tramadol Hydrochloride
38.
Tramadol Kern
39.
Tramadol Lichtenstein
40.
Tramadol Lindo
41.
Tramadol Mabo
42.
Tramadol Normon
43.
Tramadol PB
44.
Tramadol Ratiopharm
45.
Tramadol Stada
46.
Tramadol acis
47.
Tramadol-Dolgit
48.
Tramadol-Hameln
49.
Tramadol-ratiopharm
50.
Tramadolor
51.
Tramadura
52.
Tramagetic
53.
Tramagit
54.
Tramake
55.
Tramal
56.
Tramex
57.
Tramundin
58.
Trasedal
59.
Ultram
60.
Xymel 50
61.
Zamudol
62.
Zumalgic
63.
Zydol
64.
Zytram
65.
K 315
66.
K315
67.
MTW Tramadol
68.
MTWTramadol
69.
Tradol Puren
70.
TradolPuren
71.
Trama Dorsch
72.
TramaDorsch
73.
Tramadol Dolgit
74.
Tramadol Hameln
75.
TramadolDolgit
76.
TramadolHameln
77.
Tramadolratiopharm
External Link(s)
MeSHD014147
PubChem Compound63013
67108333
ChEBI75733
CHEMBLCHEMBL1200336
KEGGdr:D01355
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 266
Canada Vigilance: 21
Canada Vigilance
US FAERS
2Drug ineffectiveFAERS: 216
Canada Vigilance: 9
Canada Vigilance
US FAERS
3VomitingFAERS: 214
Canada Vigilance: 11
Canada Vigilance
US FAERS
4DizzinessFAERS: 171
Canada Vigilance: 17
Canada Vigilance
US FAERS
5OverdoseFAERS: 160US FAERS
6HypersensitivityFAERS: 116
Canada Vigilance: 1
Canada Vigilance
US FAERS
7Toxicity to various agentsFAERS: 114
Canada Vigilance: 1
Canada Vigilance
US FAERS
8PruritusFAERS: 93
Canada Vigilance: 4
Canada Vigilance
US FAERS
9Drug DependenceFAERS: 92
Canada Vigilance: 7
Canada Vigilance
US FAERS
10SomnolenceFAERS: 91
Canada Vigilance: 5
Canada Vigilance
US FAERS
11HeadacheFAERS: 79US FAERS
12Drug abuseFAERS: 76
Canada Vigilance: 1
Canada Vigilance
US FAERS
13TremorFAERS: 73
Canada Vigilance: 8
Canada Vigilance
US FAERS
14MalaiseFAERS: 68
Canada Vigilance: 3
Canada Vigilance
US FAERS
15Drug withdrawal syndromeFAERS: 64
Canada Vigilance: 5
Canada Vigilance
US FAERS
16Feeling abnormalFAERS: 57
Canada Vigilance: 3
Canada Vigilance
US FAERS
17PainFAERS: 57
Canada Vigilance: 2
Canada Vigilance
US FAERS
18Respiratory DepressionFAERS: 52US FAERS
19Completed SuicideFAERS: 51US FAERS
20AstheniaFAERS: 48
Canada Vigilance: 1
Canada Vigilance
US FAERS
21AnxietyFAERS: 45US FAERS
22Suicide attemptFAERS: 44
Canada Vigilance: 1
Canada Vigilance
US FAERS
23AgitationFAERS: 42US FAERS
24FatigueFAERS: 41
Canada Vigilance: 5
Canada Vigilance
US FAERS
25ConstipationFAERS: 38
Canada Vigilance: 5
Canada Vigilance
US FAERS
26TachycardiaFAERS: 38US FAERS
27UrticariaFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
28Intentional product misuseFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
29Drug dose omissionFAERS: 33US FAERS
30Adverse eventFAERS: 32US FAERS
31PalpitationsFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
32DisorientationFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
33Medication ErrorFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
34PoisoningFAERS: 29US FAERS
35VertigoFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
36Incorrect dose administeredFAERS: 27US FAERS
37Mental status changesFAERS: 27US FAERS
38Euphoric moodFAERS: 26US FAERS
39Abdominal PainFAERS: 24US FAERS
40DependenceFAERS: 24
Canada Vigilance: 5
Canada Vigilance
US FAERS
41Product substitution issueFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
42RestlessnessFAERS: 24US FAERS
43RhabdomyolysisFAERS: 24US FAERS
44Abdominal discomfortFAERS: 23US FAERS
45Depressed Level of ConsciousnessFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
46Accidental overdoseFAERS: 22US FAERS
47Unresponsive to stimuliFAERS: 22US FAERS
48ChillsFAERS: 21
Canada Vigilance: 3
Canada Vigilance
US FAERS
49Intentional drug misuseFAERS: 21US FAERS
50Pharmaceutical product complaintFAERS: 20US FAERS
51Unevaluable eventFAERS: 20US FAERS
52Cardiac ArrestFAERS: 19US FAERS
53Cerebrovascular accidentFAERS: 19US FAERS
54Chest PainFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
55DehydrationFAERS: 19US FAERS
56HypotensionFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
57Weight decreasedFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
58Blood creatine phosphokinase increasedFAERS: 18US FAERS
59Urinary RetentionFAERS: 18US FAERS
60Accidental drug intake by childFAERS: 17US FAERS
61Drug toxicityFAERS: 17US FAERS
62ErythemaFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
63Serotonin SyndromeFAERS: 17US FAERS
64SyncopeFAERS: 17US FAERS
65Chest discomfortFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
66CyanosisFAERS: 16US FAERS
67LethargyFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
68MyoclonusFAERS: 16US FAERS
69Respiratory arrestFAERS: 16US FAERS
70AmnesiaFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
71DeliriumFAERS: 15US FAERS
72Musculoskeletal stiffnessFAERS: 15US FAERS
73Prescription drug used without a prescriptionFAERS: 15US FAERS
74Back PainFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
75Cold sweatFAERS: 14US FAERS
76Drug screen positiveFAERS: 14US FAERS
77DysarthriaFAERS: 14US FAERS
78Electrocardiogram abnormalFAERS: 14US FAERS
79MydriasisFAERS: 14US FAERS
80PneumoniaFAERS: 14US FAERS
81FormicationFAERS: 13US FAERS
82PallorFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
83Product quality issueFAERS: 13US FAERS
84Sinus TachycardiaFAERS: 13US FAERS
85Wrong technique in drug usage processFAERS: 13US FAERS
86AcidosisFAERS: 12US FAERS
87DysgeusiaFAERS: 12US FAERS
88Erectile dysfunctionFAERS: 12US FAERS
89HemiplegiaFAERS: 12US FAERS
90HypersomniaFAERS: 12US FAERS
91Impaired work abilityFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
92Inadequate analgesiaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
93Metabolic acidosisFAERS: 12US FAERS
94ShockFAERS: 12US FAERS
95SwellingFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
96Therapeutic response unexpected with drug substitutionFAERS: 12US FAERS
97BradycardiaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
98Drug dispensing errorFAERS: 11US FAERS
99Drug exposure during pregnancyFAERS: 11US FAERS
100DysphoniaFAERS: 11US FAERS
101Inappropriate schedule of drug administrationFAERS: 11US FAERS
102TinnitusFAERS: 11US FAERS
103Visual ImpairmentFAERS: 11US FAERS
104AbasiaFAERS: 10US FAERS
105Burning sensationFAERS: 10US FAERS
106Drug administration errorFAERS: 10US FAERS
107DysuriaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
108Impaired driving abilityFAERS: 10US FAERS
109Memory impairmentFAERS: 10US FAERS
110NervousnessFAERS: 10US FAERS
111Restless Legs SyndromeFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
112SoporFAERS: 10US FAERS
113WheezingFAERS: 10US FAERS
114AngioedemaFAERS: 9US FAERS
115AnorexiaFAERS: 9US FAERS
116Drug ToleranceFAERS: 9US FAERS
117FlushingFAERS: 9US FAERS
118ImmobileFAERS: 9US FAERS
119Lip swellingFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
120Maternal exposure during pregnancyFAERS: 9US FAERS
121MyalgiaFAERS: 9US FAERS
122PancreatitisFAERS: 9US FAERS
123PresyncopeFAERS: 9US FAERS
124Product use issueFAERS: 9US FAERS
125Urinary IncontinenceFAERS: 9US FAERS
126Accidental exposureFAERS: 8US FAERS
127Altered state of consciousnessFAERS: 8US FAERS
128ArthralgiaFAERS: 8US FAERS
129Aspartate Aminotransferase IncreasedFAERS: 8US FAERS
130AtaxiaFAERS: 8US FAERS
131Blood glucose increasedFAERS: 8US FAERS
132Depressed moodFAERS: 8US FAERS
133HypoventilationFAERS: 8US FAERS
134HypoxiaFAERS: 8US FAERS
135Multiple drug overdoseFAERS: 8US FAERS
136OpisthotonusFAERS: 8US FAERS
137ParanoiaFAERS: 8US FAERS
138Respiratory FailureFAERS: 8US FAERS
139Respiratory distressFAERS: 8US FAERS
140Wrong drug administeredFAERS: 8US FAERS
141Bone painFAERS: 7US FAERS
142ClonusFAERS: 7US FAERS
143CryingFAERS: 7US FAERS
144DementiaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
145Drug level increasedFAERS: 7US FAERS
146DystoniaFAERS: 7US FAERS
147EpilepsyFAERS: 7US FAERS
148Feeling ColdFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
149Middle insomniaFAERS: 7US FAERS
150Muscle tightnessFAERS: 7US FAERS
151Prescription form tamperingFAERS: 7US FAERS
152Rash erythematousFAERS: 7US FAERS
153RetchingFAERS: 7US FAERS
154SepsisFAERS: 7US FAERS
155Alanine Aminotransferase IncreasedFAERS: 6US FAERS
156AlopeciaFAERS: 6US FAERS
157Analgesic drug level above therapeuticFAERS: 6US FAERS
158Analgesic drug level increasedFAERS: 6US FAERS
159Atrial FibrillationFAERS: 6US FAERS
160Blood potassium increasedFAERS: 6US FAERS
161DiscomfortFAERS: 6US FAERS
162Drug ineffective for unapproved indicationFAERS: 6US FAERS
163Feeling jitteryFAERS: 6US FAERS
164FlatulenceFAERS: 6US FAERS
165HypokinesiaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
166NeuralgiaFAERS: 6US FAERS
167ScreamingFAERS: 6US FAERS
168StarvationFAERS: 6US FAERS
169Therapeutic response unexpectedFAERS: 6US FAERS
170Accidental deathFAERS: 5US FAERS
171Accidental exposure to product by childFAERS: 5US FAERS
172AngerFAERS: 5US FAERS
173ApathyFAERS: 5US FAERS
174Blood creatinine increasedFAERS: 5US FAERS
175Drug abuserFAERS: 5US FAERS
176Drug diversionFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
177Electrocardiogram changeFAERS: 5US FAERS
178HypophagiaFAERS: 5US FAERS
179IleusFAERS: 5US FAERS
180InfluenzaFAERS: 5US FAERS
181Intestinal ObstructionFAERS: 5US FAERS
182Loss of personal independence in daily activitiesFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
183Neck PainFAERS: 5US FAERS
184PhotophobiaFAERS: 5US FAERS
185Product taste abnormalFAERS: 5US FAERS
186ThirstFAERS: 5US FAERS
187Visceral congestionFAERS: 5US FAERS
188nervous system disorderFAERS: 5US FAERS
189Accidental exposure to productFAERS: 4US FAERS
190Acute kidney injuryFAERS: 4US FAERS
191Anaphylactic shockFAERS: 4US FAERS
192AphasiaFAERS: 4US FAERS
193AsterixisFAERS: 4US FAERS
194AsthmaFAERS: 4US FAERS
195CardiomegalyFAERS: 4US FAERS
196Coronary Artery DiseaseFAERS: 4US FAERS
197Drug effect incompleteFAERS: 4US FAERS
198Drug level above therapeuticFAERS: 4US FAERS
199Drug screen false positiveFAERS: 4US FAERS
200Drug withdrawal convulsionsFAERS: 4US FAERS
201Economic problemFAERS: 4US FAERS
202Electrolyte imbalanceFAERS: 4US FAERS
203Emotional disorderFAERS: 4US FAERS
204Expired drug administeredFAERS: 4US FAERS
205Freezing phenomenonFAERS: 4US FAERS
206HyperreflexiaFAERS: 4US FAERS
207HyporeflexiaFAERS: 4US FAERS
208IncoherentFAERS: 4US FAERS
209Incorrect drug administration durationFAERS: 4US FAERS
210InfectionFAERS: 4US FAERS
211Joint stiffnessFAERS: 4US FAERS
212Joint swellingFAERS: 4US FAERS
213Medication tamperingFAERS: 4US FAERS
214Multi-organ disorderFAERS: 4US FAERS
215Multiple allergiesFAERS: 4US FAERS
216Muscle RigidityFAERS: 4US FAERS
217Musculoskeletal PainFAERS: 4US FAERS
218Myocardial InfarctionFAERS: 4US FAERS
219Poor quality sleepFAERS: 4US FAERS
220RegurgitationFAERS: 4US FAERS
221Status EpilepticusFAERS: 4US FAERS
222Supraventricular tachycardiaFAERS: 4US FAERS
223Troponin I increasedFAERS: 4US FAERS
224Activities of daily living impairedFAERS: 3US FAERS
225AgranulocytosisFAERS: 3US FAERS
226Angina PectorisFAERS: 3US FAERS
227Anticholinergic SyndromeFAERS: 3US FAERS
228Apparent life threatening eventFAERS: 3US FAERS
229AscitesFAERS: 3US FAERS
230Blood lactate dehydrogenase increasedFAERS: 3US FAERS
231Blood urine presentFAERS: 3US FAERS
232Breakthrough PainFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
233BruxismFAERS: 3US FAERS
234Drug prescribing errorFAERS: 3US FAERS
235Electrocardiogram repolarisation abnormalityFAERS: 3US FAERS
236Extra dose administeredFAERS: 3US FAERS
237Feeding disorder neonatalFAERS: 3US FAERS
238Feeling of body temperature changeFAERS: 3US FAERS
239Gastric ulcerFAERS: 3US FAERS
240Grip strength decreasedFAERS: 3US FAERS
241HepatomegalyFAERS: 3US FAERS
242HypomaniaFAERS: 3US FAERS
243Intentional self-injuryFAERS: 3US FAERS
244Joint injuryFAERS: 3US FAERS
245MonoparesisFAERS: 3US FAERS
246Mood swingsFAERS: 3US FAERS
247Morbid thoughtsFAERS: 3US FAERS
248NephrosclerosisFAERS: 3US FAERS
249Panic DisorderFAERS: 3US FAERS
250Reaction to drug excipientsFAERS: 3US FAERS
251Rectal tenesmusFAERS: 3US FAERS
252Sinus bradycardiaFAERS: 3US FAERS
253SneezingFAERS: 3US FAERS
254StomatitisFAERS: 3US FAERS
255Tardive DyskinesiaFAERS: 3US FAERS
256Therapy cessationFAERS: 3US FAERS
257Throat irritationFAERS: 3US FAERS
258ThrombosisFAERS: 3US FAERS
259Traumatic Brain InjuryFAERS: 3US FAERS
260TrismusFAERS: 3US FAERS
261UlcerFAERS: 3US FAERS
262Urinary tract infectionFAERS: 3US FAERS
263jaundiceFAERS: 3US FAERS
264Alcohol abuseFAERS: 2US FAERS
265AphagiaFAERS: 2US FAERS
266ArthritisFAERS: 2US FAERS
267BlindnessFAERS: 2US FAERS
268Blood creatine phosphokinase MB increasedFAERS: 2US FAERS
269Blood glucose decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
270Blood potassium decreasedFAERS: 2US FAERS
271Blood sodium abnormalFAERS: 2US FAERS
272Blood urea increasedFAERS: 2US FAERS
273BronchopneumoniaFAERS: 2US FAERS
274CardiotoxicityFAERS: 2US FAERS
275ChromaturiaFAERS: 2US FAERS
276Circumstance or information capable of leading to medication errorFAERS: 2US FAERS
277ConjunctivitisFAERS: 2US FAERS
278Consciousness fluctuatingFAERS: 2US FAERS
279DeafnessFAERS: 2US FAERS
280Deep Vein ThrombosisFAERS: 2US FAERS
281Dental cariesFAERS: 2US FAERS
282Diabetes InsipidusFAERS: 2US FAERS
283Disseminated Intravascular CoagulationFAERS: 2US FAERS
284DiverticulitisFAERS: 2US FAERS
285DroolingFAERS: 2US FAERS
286DrowningFAERS: 2US FAERS
287Drug exposure via breast milkFAERS: 2US FAERS
288Duodenal UlcerFAERS: 2US FAERS
289DysphemiaFAERS: 2US FAERS
290Erythema MultiformeFAERS: 2US FAERS
291ExcoriationFAERS: 2US FAERS
292Eye irritationFAERS: 2US FAERS
293Eye painFAERS: 2US FAERS
294Facial paralysisFAERS: 2US FAERS
295False negative investigation resultFAERS: 2US FAERS
296FractureFAERS: 2US FAERS
297Gastrointestinal sounds abnormalFAERS: 2US FAERS
298Gaze palsyFAERS: 2US FAERS
299General physical health deteriorationFAERS: 2US FAERS
300HepatosplenomegalyFAERS: 2US FAERS
301HomicideFAERS: 2US FAERS
302HyperacusisFAERS: 2US FAERS
303HypercapniaFAERS: 2US FAERS
304Hypertensive crisisFAERS: 2US FAERS
305HyperventilationFAERS: 2US FAERS
306Impaired gastric emptyingFAERS: 2US FAERS
307Incorrect route of drug administrationFAERS: 2US FAERS
308Initial insomniaFAERS: 2US FAERS
309Injection site abscessFAERS: 2US FAERS
310Intentional misuseFAERS: 2US FAERS
311Intentional product use issueFAERS: 2US FAERS
312Limb discomfortFAERS: 2US FAERS
313Malignant neoplasm progressionFAERS: 2US FAERS
314Mental impairmentFAERS: 2US FAERS
315Near DrowningFAERS: 2US FAERS
316Neonatal disorderFAERS: 2US FAERS
317Neonatal tachycardiaFAERS: 2US FAERS
318Nerve injuryFAERS: 2US FAERS
319Neutrophil percentage increasedFAERS: 2US FAERS
320Night sweatsFAERS: 2US FAERS
321No reaction on previous exposure to drugFAERS: 2US FAERS
322NystagmusFAERS: 2US FAERS
323Obsessive-Compulsive DisorderFAERS: 2US FAERS
324ObstructionFAERS: 2US FAERS
325Peripheral swellingFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
326PharyngitisFAERS: 2US FAERS
327Pneumatosis intestinalisFAERS: 2US FAERS
328Poor quality drug administeredFAERS: 2US FAERS
329Product dispensing errorFAERS: 2US FAERS
330Product formulation issueFAERS: 2US FAERS
331Product packaging issueFAERS: 2US FAERS
332Productive CoughFAERS: 2US FAERS
333Pulmonary EmbolismFAERS: 2US FAERS
334Pulmonary congestionFAERS: 2US FAERS
335Renal cystFAERS: 2US FAERS
336SchizophreniaFAERS: 2US FAERS
337Septic ShockFAERS: 2US FAERS
338SluggishnessFAERS: 2US FAERS
339SomnambulismFAERS: 2US FAERS
340Spermatozoa progressive motility decreasedFAERS: 2US FAERS
341Spinal column stenosisFAERS: 2US FAERS
342Tablet physical issueFAERS: 2US FAERS
343TachyphreniaFAERS: 2US FAERS
344Tongue bitingFAERS: 2US FAERS
345TorticollisFAERS: 2US FAERS
346Transaminases increasedFAERS: 2US FAERS
347Urine flow decreasedFAERS: 2US FAERS
348Victim of sexual abuseFAERS: 2US FAERS
349Vitamin D DeficiencyFAERS: 2US FAERS
350Wrong technique in product usage processFAERS: 2US FAERS
351treatment failureFAERS: 2US FAERS
352Abdominal tendernessFAERS: 1US FAERS
353AcneFAERS: 1US FAERS
354Acute myocardial infarctionFAERS: 1US FAERS
355Acute psychosisFAERS: 1US FAERS
356AgoraphobiaFAERS: 1US FAERS
357Alcohol poisoningFAERS: 1US FAERS
358Ammonia increasedFAERS: 1US FAERS
359Anal FistulaFAERS: 1US FAERS
360Angle Closure GlaucomaFAERS: 1US FAERS
361Ankle FractureFAERS: 1US FAERS
362Antisocial Personality DisorderFAERS: 1US FAERS
363AnuriaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
364AphoniaFAERS: 1US FAERS
365Apparent deathFAERS: 1US FAERS
366Arcus lipoidesFAERS: 1US FAERS
367ArteriosclerosisFAERS: 1US FAERS
368ArthropathyFAERS: 1US FAERS
369Arthropod biteFAERS: 1US FAERS
370AsphyxiaFAERS: 1US FAERS
371Back disorderFAERS: 1US FAERS
372Benign Prostatic HyperplasiaFAERS: 1US FAERS
373Bipolar DisorderFAERS: 1US FAERS
374Bladder NeoplasmFAERS: 1US FAERS
375Blood antidiuretic hormone increasedFAERS: 1US FAERS
376Blood bilirubin abnormalFAERS: 1US FAERS
377Blood cholesterol increasedFAERS: 1US FAERS
378Blood count abnormalFAERS: 1US FAERS
379Blood creatine increasedFAERS: 1US FAERS
380Blood gases abnormalFAERS: 1US FAERS
381Blood glucose abnormalFAERS: 1US FAERS
382Blood iron decreasedFAERS: 1US FAERS
383Blood magnesium decreasedFAERS: 1US FAERS
384Blood potassium abnormalFAERS: 1US FAERS
385Blood pressure immeasurableFAERS: 1US FAERS
386Blood pressure inadequately controlledFAERS: 1US FAERS
387Blood pressure orthostatic decreasedFAERS: 1US FAERS
388Blood sodium decreasedFAERS: 1US FAERS
389Blood triglycerides increasedFAERS: 1US FAERS
390Blood urea nitrogen/creatinine ratio increasedFAERS: 1US FAERS
391Borderline Personality DisorderFAERS: 1US FAERS
392Bowel movement irregularityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
393BradyphreniaFAERS: 1US FAERS
394BronchospasmFAERS: 1US FAERS
395BursitisFAERS: 1US FAERS
396Cardiac HypertrophyFAERS: 1US FAERS
397Cardiac stress test abnormalFAERS: 1US FAERS
398Cerebral ArteriosclerosisFAERS: 1US FAERS
399Cerebral InfarctionFAERS: 1US FAERS
400Cerebral atrophyFAERS: 1US FAERS
401ChokingFAERS: 1US FAERS
402CholelithiasisFAERS: 1US FAERS
403CircumstantialityFAERS: 1US FAERS
404Cleft PalateFAERS: 1US FAERS
405Cleft uvulaFAERS: 1US FAERS
406ClumsinessFAERS: 1US FAERS
407Coma scale abnormalFAERS: 1US FAERS
408Complex partial seizuresFAERS: 1US FAERS
409Compression fractureFAERS: 1US FAERS
410Contraindicated product administeredFAERS: 1US FAERS
411Conversion disorderFAERS: 1US FAERS
412Counterfeit drug administeredFAERS: 1US FAERS
413CystitisFAERS: 1US FAERS
414Cytolytic hepatitisFAERS: 1US FAERS
415Decompression SicknessFAERS: 1US FAERS
416Delusional disorder, persecutory typeFAERS: 1US FAERS
417Diabetes MellitusFAERS: 1US FAERS
418DiplegiaFAERS: 1US FAERS
419DisabilityFAERS: 1US FAERS
420Disease recurrenceFAERS: 1US FAERS
421DiverticulumFAERS: 1US FAERS
422Dry skinFAERS: 1US FAERS
423DyscheziaFAERS: 1US FAERS
424DysmorphismFAERS: 1US FAERS
425DyspepsiaFAERS: 1US FAERS
426Ear discomfortFAERS: 1US FAERS
427Ectopic PregnancyFAERS: 1US FAERS
428Emergency CareFAERS: 1US FAERS
429Emotional distressFAERS: 1US FAERS
430EnuresisFAERS: 1US FAERS
431Epigastric discomfortFAERS: 1US FAERS
432EpiglottitisFAERS: 1US FAERS
433EpistaxisFAERS: 1US FAERS
434Excessive eye blinkingFAERS: 1US FAERS
435ExophthalmosFAERS: 1US FAERS
436Exposure to toxic agentFAERS: 1US FAERS
437Exposure via breast milkFAERS: 1US FAERS
438Eye inflammationFAERS: 1US FAERS
439Failure of child resistant mechanism for pharmaceutical productFAERS: 1US FAERS
440False positive laboratory resultFAERS: 1US FAERS
441FibromyalgiaFAERS: 1US FAERS
442Flank PainFAERS: 1US FAERS
443Flat affectFAERS: 1US FAERS
444Flight of ideasFAERS: 1US FAERS
445Foaming at mouthFAERS: 1US FAERS
446Food AllergyFAERS: 1US FAERS
447Food aversionFAERS: 1US FAERS
448Foreign body traumaFAERS: 1US FAERS
449GastritisFAERS: 1US FAERS
450Gastrointestinal PainFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
451Gastrointestinal hypomotilityFAERS: 1US FAERS
452Gastrointestinal ulcerFAERS: 1US FAERS
453Gestational DiabetesFAERS: 1US FAERS
454GoutFAERS: 1US FAERS
455GranulomaFAERS: 1US FAERS
456Guillain-Barre SyndromeFAERS: 1US FAERS
457Hallucinations, mixedFAERS: 1US FAERS
458Heat StrokeFAERS: 1US FAERS
459HemiparesisFAERS: 1US FAERS
460Hepatic Vein ThrombosisFAERS: 1US FAERS
461Hepatitis C virus test positiveFAERS: 1US FAERS
462HyperchlorhydriaFAERS: 1US FAERS
463HyperthyroidismFAERS: 1US FAERS
464HypervigilanceFAERS: 1US FAERS
465Illogical thinkingFAERS: 1US FAERS
466ImpatienceFAERS: 1US FAERS
467Inappropriate affectFAERS: 1US FAERS
468IncontinenceFAERS: 1US FAERS
469Incorrect drug dosage form administeredFAERS: 1US FAERS
470InfarctionFAERS: 1US FAERS
471InflammationFAERS: 1US FAERS
472Infusion site abscessFAERS: 1US FAERS
473Intercepted drug dispensing errorFAERS: 1US FAERS
474Intercepted medication errorFAERS: 1US FAERS
475Intercepted wrong patient selectedFAERS: 1US FAERS
476Internal injuryFAERS: 1US FAERS
477IntubationFAERS: 1US FAERS
478LacerationFAERS: 1US FAERS
479LeukocytosisFAERS: 1US FAERS
480Lid lagFAERS: 1US FAERS
481Limb asymmetryFAERS: 1US FAERS
482Lyme DiseaseFAERS: 1US FAERS
483Macular degenerationFAERS: 1US FAERS
484MalacoplakiaFAERS: 1US FAERS
485Mastication disorderFAERS: 1US FAERS
486Mechanical ventilationFAERS: 1US FAERS
487Medication residue presentFAERS: 1US FAERS
488MeningitisFAERS: 1US FAERS
489MetamorphopsiaFAERS: 1US FAERS
490MetaplasiaFAERS: 1US FAERS
491Mucosal erosionFAERS: 1US FAERS
492MyopathyFAERS: 1US FAERS
493Narcotic intoxicationFAERS: 1US FAERS
494NasopharyngitisFAERS: 1US FAERS
495NephrolithiasisFAERS: 1US FAERS
496Neuroleptic Malignant SyndromeFAERS: 1US FAERS
497NeutropeniaFAERS: 1US FAERS
498No adverse eventFAERS: 1US FAERS
499Nonspecific reactionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
500ObesityFAERS: 1US FAERS
501Occult blood positiveFAERS: 1US FAERS
502Oculogyric crisisFAERS: 1US FAERS
503OnychoclasisFAERS: 1US FAERS
504Opiates positiveFAERS: 1US FAERS
505Optic NeuritisFAERS: 1US FAERS
506Oral pruritusFAERS: 1US FAERS
507Oropharyngeal painFAERS: 1US FAERS
508OtotoxicityFAERS: 1US FAERS
509PO2 decreasedFAERS: 1US FAERS
510Pain of skinFAERS: 1US FAERS
511Peptic UlcerFAERS: 1US FAERS
512Peripheral arterial occlusive diseaseFAERS: 1US FAERS
513Peroneal nerve injuryFAERS: 1US FAERS
514Persistent depressive disorderFAERS: 1US FAERS
515Pharmaceutical product counterfeitFAERS: 1US FAERS
516Physical assaultFAERS: 1US FAERS
517PiloerectionFAERS: 1US FAERS
518PolydipsiaFAERS: 1US FAERS
519Post procedural complicationFAERS: 1US FAERS
520Post-Traumatic Stress DisorderFAERS: 1US FAERS
521Predisposition to diseaseFAERS: 1US FAERS
522Premature EjaculationFAERS: 1US FAERS
523Pressure of speechFAERS: 1US FAERS
524PriapismFAERS: 1US FAERS
525Product administration errorFAERS: 1US FAERS
526Product coating issueFAERS: 1US FAERS
527Product comminglingFAERS: 1US FAERS
528Product contamination chemicalFAERS: 1US FAERS
529Product dropper issueFAERS: 1US FAERS
530Product label issueFAERS: 1US FAERS
531Product measured potency issueFAERS: 1US FAERS
532Product solubility abnormalFAERS: 1US FAERS
533Product tamperingFAERS: 1US FAERS
534Product use complaintFAERS: 1US FAERS
535Product use in unapproved indicationFAERS: 1US FAERS
536ProteinuriaFAERS: 1US FAERS
537Psychotic symptomFAERS: 1US FAERS
538Pulmonary FibrosisFAERS: 1US FAERS
539Pulmonary painFAERS: 1US FAERS
540Reaction to excipientFAERS: 1US FAERS
541Rebound effectFAERS: 1US FAERS
542Rehabilitation therapyFAERS: 1US FAERS
543Reversed hot-cold sensationFAERS: 1US FAERS
544Reversible cerebral vasoconstriction syndromeFAERS: 1US FAERS
545Rheumatoid ArthritisFAERS: 1US FAERS
546Selective eating disorderFAERS: 1US FAERS
547Sexual DysfunctionFAERS: 1US FAERS
548SinusitisFAERS: 1US FAERS
549Skin PapillomaFAERS: 1US FAERS
550Skin irritationFAERS: 1US FAERS
551Skin lacerationFAERS: 1US FAERS
552Skin reactionFAERS: 1US FAERS
553Slow speechFAERS: 1US FAERS
554SnoringFAERS: 1US FAERS
555Spinal fusion surgeryFAERS: 1US FAERS
556Splenic RuptureFAERS: 1US FAERS
557Stevens-Johnson SyndromeFAERS: 1US FAERS
558StressFAERS: 1US FAERS
559Substance-induced mood disorderFAERS: 1US FAERS
560Sudden deathFAERS: 1US FAERS
561SunburnFAERS: 1US FAERS
562Superficial injury of eyeFAERS: 1US FAERS
563Swelling of eyelidFAERS: 1US FAERS
564TensionFAERS: 1US FAERS
565TheftFAERS: 1US FAERS
566Therapeutic agent urine negativeFAERS: 1US FAERS
567Therapeutic procedureFAERS: 1US FAERS
568Therapeutic product effect incompleteFAERS: 1US FAERS
569Therapeutic product ineffectiveFAERS: 1US FAERS
570Therapeutic response delayedFAERS: 1US FAERS
571Therapy non-responderFAERS: 1US FAERS
572ThrombocytopeniaFAERS: 1US FAERS
573Tongue movement disturbanceFAERS: 1US FAERS
574Tongue spasmFAERS: 1US FAERS
575Tonic clonic movementsFAERS: 1US FAERS
576Tooth LossFAERS: 1US FAERS
577ToothacheFAERS: 1US FAERS
578Toxic Epidermal NecrolysisFAERS: 1US FAERS
579Toxicologic test abnormalFAERS: 1US FAERS
580Troponin increasedFAERS: 1US FAERS
581Umbilical herniaFAERS: 1US FAERS
582Urinary hesitationFAERS: 1US FAERS
583VasculitisFAERS: 1US FAERS
584Venous occlusionFAERS: 1US FAERS
585Visual disturbanceFAERS: 1US FAERS
586Vital functions abnormalFAERS: 1US FAERS
587Vitreous DetachmentFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
588Vitreous floatersFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
589Vocal Cord DysfunctionFAERS: 1US FAERS
590Vocal Cord ParalysisFAERS: 1US FAERS
591Vulvovaginal pruritusFAERS: 1US FAERS
592Weight decrease neonatalFAERS: 1US FAERS
593Wrong doseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
594Wrong patient received medicationFAERS: 1US FAERS
595YawningFAERS: 1US FAERS
596muscle injuryFAERS: 1US FAERS
597Anaphylactoid ReactionCanada Vigilance: 1Canada Vigilance
598Inappropriate schedule of product administrationCanada Vigilance: 1Canada Vigilance
599Ocular icterusCanada Vigilance: 1Canada Vigilance
600Product complaintCanada Vigilance: 1Canada Vigilance
601Product residue presentCanada Vigilance: 2Canada Vigilance
602Transient psychosisCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.